Diagnostic options · UAE

Single Gene tests in Dubai & UAE

Compare available Single Gene tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

332

Listed price range

2,000.00–2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Single Gene test prices

Showing 226–240 of 332 matching tests.

Single Gene diagnostic tests, details, and listed prices
Test and description	Specimen	Typical duration	Price	Options
TEST-4555 PLA2G6 Gene: Infantile Neuroaxonal Dystrophy Type 1 (INAD) Genetic Test This test identifies pathogenic variants in the PLA2G6 gene associated with Infantile Neuroaxonal Dystrophy Type 1 (INAD).	Whole blood (2-5 mL EDTA), extracted DNA, or FTA card	3–4 weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PLA2G6 gene pathogenic variants", "Mutations causing INAD"] Parameters [] Preparation ["No special fasting required.", "Continue prescribed medications."] Indications ["Suspected Infantile Neuroaxonal Dystrophy Type 1 (INAD)", "Progressive neurological decline in early childhood"] Measurement technique Confirm with laboratory Codes LOINC: 78146-2 ICD-10: G31.89 Clinical summary This test identifies pathogenic variants in the PLA2G6 gene associated with Infantile Neuroaxonal Dystrophy Type 1 (INAD).
TEST-4667 PLEKHM1 Gene Osteopetrosis, Autosomal Recessive Type 6 Genetic Test This genetic test identifies mutations in the PLEKHM1 gene associated with autosomal recessive osteopetrosis type 6.	Peripheral whole blood, extracted DNA, or FTA card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PLEKHM1 gene mutations", "Coding exons", "Splice sites"] Parameters [] Preparation [] Indications ["Suspected diagnosis of autosomal recessive osteopetrosis type 6", "Family history of osteopetrosis type 6", "Genetic counselling for affected families"] Measurement technique Confirm with laboratory Codes LOINC: 81409-7 ICD-10: Q78.2 Clinical summary This genetic test identifies mutations in the PLEKHM1 gene associated with autosomal recessive osteopetrosis type 6.
TEST-6368 PMM2 Gene Glycosylation Disorder Type 1A Genetic Test This genetic test identifies mutations in the PMM2 gene associated with Congenital Disorder of Glycosylation Type 1A.	Whole Blood (EDTA)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PMM2 gene", "Single-nucleotide variants", "Indels", "CNVs"] Parameters [{"name": "Diagnostic Sensitivity", "reference_range": "99.9% for single-nucleotide variants, indels, and CNVs"}] Preparation ["No fasting required.", "Mandatory genetic counselling session."] Indications ["Suspected Congenital Disorder of Glycosylation Type 1A", "Carrier testing", "Familial risk assessment"] Measurement technique Confirm with laboratory Codes LOINC: 83024-6 ICD-10: E77.8 Clinical summary This genetic test identifies mutations in the PMM2 gene associated with Congenital Disorder of Glycosylation Type 1A.
TEST-5385 PNPLA2 Gene Neutral Lipid Storage Disease with Myopathy (NLSDM) Genetic Test This genetic test identifies pathogenic variants in the PNPLA2 gene associated with Neutral Lipid Storage Disease with Myopathy (NLSDM).	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot on FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PNPLA2 gene sequence", "Pathogenic variants in PNPLA2"] Parameters [] Preparation [] Indications ["Clinical suspicion of NLSDM", "Unexplained progressive myopathy", "Family history of NLSDM", "Elevated creatine kinase with myopathy or cardiomyopathy"] Measurement technique Confirm with laboratory Codes LOINC: 94218-7 ICD-10: E75.5 Clinical summary This genetic test identifies pathogenic variants in the PNPLA2 gene associated with Neutral Lipid Storage Disease with Myopathy (NLSDM).
TEST-6231 PNPT1 Gene Combined Oxidative Phosphorylation Deficiency Type 13 Genetic Test This test analyzes the PNPT1 gene to identify pathogenic variants associated with Combined Oxidative Phosphorylation Deficiency Type 13.	Peripheral whole blood (EDTA tube)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["PNPT1 gene variants", "Combined Oxidative Phosphorylation Deficiency Type 13"] Parameters [] Preparation ["No fasting required", "No medication alterations necessary", "Pre-test genetic counselling session required"] Indications ["Suspected mitochondrial disease", "Family screening for PNPT1-related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 92988-2 ICD-10: E88.49 Clinical summary This test analyzes the PNPT1 gene to identify pathogenic variants associated with Combined Oxidative Phosphorylation Deficiency Type 13.
TEST-2837 POLE Gene (FILS Syndrome) Genetic Test This test identifies pathogenic variants within the POLE gene using next-generation sequencing.	Peripheral Whole Blood	3 – 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POLE gene", "Single nucleotide variants (SNVs)", "Small insertions and deletions (indels)", "Copy number variants (CNVs)"] Parameters [] Preparation ["Pre-test genetic counseling session required", "Signed informed consent required"] Indications ["Suspected FILS syndrome", "Family history of FILS syndrome", "Evaluation of immunodeficiency with associated features"] Measurement technique Confirm with laboratory Codes LOINC: 69548-6 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants within the POLE gene using next-generation sequencing.
TEST-3620 POMC Gene Obesity, Early-Onset, Susceptibility Test This genetic test evaluates the POMC gene for pathogenic variants linked to severe early-onset obesity and related endocrine disorders.	Peripheral Whole Blood	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the POMC gene", "Copy Number Variants (CNVs) in the POMC gene"] Parameters [] Preparation ["No specific fasting required", "No medication or diet restrictions"] Indications ["Suspected proopiomelanocortin deficiency", "Severe obesity presenting in infancy or early childhood", "Family history of early-onset obesity with endocrine features"] Measurement technique Confirm with laboratory Codes LOINC: 94233-4 ICD-10: E66.09 Clinical summary This genetic test evaluates the POMC gene for pathogenic variants linked to severe early-onset obesity and related endocrine disorders.
TEST-5175 POMGNT1 Gene Muscular Dystrophy-Dystroglycanopathy (Congenital with Brain and Eye Anomalies), Type A3 Genetic Test This genetic test identifies disease-causing mutations in the POMGNT1 gene, confirming congenital muscular dystrophy with brain and eye anomalies.	Peripheral Whole Blood (3–5 mL in EDTA Tube) or DNA FTA Card	3–4 Weeks (21–28 Calendar Days)	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POMGNT1 gene sequence variants", "Copy Number Variants (CNVs) in POMGNT1 gene"] Parameters [] Preparation ["No fasting or special preparation is required.", "Inform phlebotomist about anticoagulant medications."] Indications ["Suspected congenital muscular dystrophy-dystroglycanopathy", "Clinical presentation consistent with Walker-Warburg syndrome or muscle-eye-brain disease", "Family history of related disorders"] Measurement technique Confirm with laboratory Codes LOINC: 78005-7 ICD-10: G71.2, Q87.8 Clinical summary This genetic test identifies disease-causing mutations in the POMGNT1 gene, confirming congenital muscular dystrophy with brain and eye anomalies.
TEST-5189 POMGNT1 Gene Muscular Dystrophy-Dystroglycanopathy (Limb-Girdle), Type C3 Genetic Test This genetic test analyzes the POMGNT1 gene to detect mutations associated with limb-girdle muscular dystrophy-dystroglycanopathy type C3.	Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POMGNT1 gene coding region", "Copy Number Variations (CNV) in POMGNT1"] Parameters [] Preparation ["No specific fasting required", "Inform phlebotomist of anticoagulant therapy"] Indications ["Suspected limb-girdle muscular dystrophy-dystroglycanopathy type C3", "Family history of dystroglycanopathy", "Evaluation for emerging gene-directed therapies"] Measurement technique Confirm with laboratory Codes LOINC: 82373-2 ICD-10: G71.0 Clinical summary This genetic test analyzes the POMGNT1 gene to detect mutations associated with limb-girdle muscular dystrophy-dystroglycanopathy type C3.
TEST-5146 POMK Gene (Muscle-Eye-Brain Disease) Genetic Test This test evaluates the POMK gene for pathogenic variants associated with muscle-eye-brain disease, a form of congenital muscular dystrophy.	Whole Blood (Peripheral Blood)	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POMK gene coding region", "POMK gene splice sites", "Pathogenic variants (point mutations, small indels)"] Parameters [] Preparation ["No fasting required", "Provide detailed clinical history", "Consent to genetic counseling"] Indications ["Suspected muscle-eye-brain disease (dystroglycanopathy type A1)", "Family history of related disorders", "Need for accurate diagnosis and prognosis"] Measurement technique Confirm with laboratory Codes LOINC: 91036-9 ICD-10: G71.0 Clinical summary This test evaluates the POMK gene for pathogenic variants associated with muscle-eye-brain disease, a form of congenital muscular dystrophy.
TEST-2442 POU1F1 Gene Pituitary Hormone Deficiency Type 1 Genetic Test This test evaluates the POU1F1 gene for variants associated with combined pituitary hormone deficiency type 1 (CPHD1).	Whole Blood, Buccal Swab, or FTA Card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["POU1F1 gene variants", "Pathogenic and likely-pathogenic variants"] Parameters [] Preparation ["No specific fasting required", "No medication adjustments needed"] Indications ["Suspected combined pituitary hormone deficiency type 1", "Family history of CPHD1", "Evaluation of growth failure", "Evaluation of neonatal endocrine emergencies"] Measurement technique Confirm with laboratory Codes LOINC: 101367-9 ICD-10: E23.0 Clinical summary This test evaluates the POU1F1 gene for variants associated with combined pituitary hormone deficiency type 1 (CPHD1).
TEST-3737 PREPL Gene Hypotonia‑Cystinuria Syndrome Genetic Test This genetic test identifies pathogenic variants in the PREPL gene, confirming a diagnosis of hypotonia-cystinuria syndrome.	Whole Blood (EDTA) or FTA Card	3-4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PREPL gene"] Parameters [] Preparation [] Indications ["Unexplained hypotonia", "Recurrent renal stones", "Endocrine disturbances suggestive of the syndrome"] Measurement technique Confirm with laboratory Codes LOINC: 55233-1 ICD-10: E72.01 Clinical summary This genetic test identifies pathogenic variants in the PREPL gene, confirming a diagnosis of hypotonia-cystinuria syndrome.
TEST-3010 PRG4 Gene Sequencing (CACP Syndrome) Test This test identifies pathogenic variants in the PRG4 gene, providing molecular confirmation for CACP syndrome.	Peripheral blood (2–5 mL EDTA), extracted DNA, or dried blood spot (FTA card)	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRG4 gene", "Coding region variants", "Intronic splice-site variants"] Parameters [] Preparation [] Indications ["Individuals with clinical features suggestive of CACP syndrome", "Family members of known carriers to clarify recurrence risks"] Measurement technique Confirm with laboratory Codes LOINC: 103438-9 ICD-10: Q87.8 Clinical summary This test identifies pathogenic variants in the PRG4 gene, providing molecular confirmation for CACP syndrome.
TEST-6358 PRKAG2 Gene Glycogen Storage Disease of Heart (Lethal) Genetic Test This genetic test identifies pathogenic variants in the PRKAG2 gene associated with a severe, often fatal, form of heart muscle disease (cardiomyopathy). It helps confirm the diagn...	Whole Blood (EDTA), Extracted DNA, or FTA Card	3 to 4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRKAG2 gene", "Glycogen storage cardiomyopathy risk"] Parameters [] Preparation ["No specific fasting required", "Inform lab of recent blood transfusions"] Indications ["Diagnosis of suspected PRKAG2-related cardiomyopathy", "Family screening for PRKAG2 variants", "Pre-implantation genetic diagnosis (PGD)", "Risk assessment for implantable cardioverter-defibrillator (ICD) placement"] Measurement technique Confirm with laboratory Codes LOINC: 48758-1 ICD-10: Z13.71 Clinical summary This genetic test identifies pathogenic variants in the PRKAG2 gene associated with a severe, often fatal, form of heart muscle disease (cardiomyopathy). It helps confirm the diagnosis and assess risk.
TEST-5573 PRPS1 Gene Sequencing for X‑Linked Deafness Type 1 (DFNX1) Test This test evaluates the PRPS1 gene for pathogenic variants associated with X-linked sensorineural deafness type 1.	Whole blood (EDTA), Extracted DNA, FTA card	3–4 Weeks	2,800.00 AED	View
View test specifications and preparation Hide test specifications and preparation What it measures ["Pathogenic variants in the PRPS1 gene", "Coding region and exon-intron boundaries"] Parameters [] Preparation [] Indications ["Individuals with a family history of early-onset X-linked hearing loss", "Males with unexplained progressive deafness", "Female carriers planning pregnancy to determine recurrence risk"] Measurement technique Confirm with laboratory Codes LOINC: 76943-6 ICD-10: H90.3 Clinical summary This test evaluates the PRPS1 gene for pathogenic variants associated with X-linked sensorineural deafness type 1.

Category overview

Single Gene: overview

When clinical symptoms or family history point directly toward a specific inherited condition, highly focused genetic testing provides the exact, rapid insights necessary for peace of mind. Integrated into our advanced Molecular Genetics services, Single Gene testing meticulously analyzes one specific gene for known disease-causing mutations. Utilizing cutting-edge diagnostic technology, this highly focused molecular screening helps confirm or rule out precise genetic traits, safely guiding targeted medical interventions and family planning strategies. Recognized for specialized diagnostic excellence among diagnostic labs in the UAE, DNA Labs ensures absolute patient confidentiality, exceptional analytical precision, and incredibly efficient turnaround times. Take an informed step forward in your health journey—schedule your single gene testing in UAE, book a secure home sample collection, or reach out to our expert medical professionals.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.